MA-BRIGHTCOVE/WIBBITZ
Media professionals, marketers, and corporate communicators can now rapidly expand their catalogs of business video with a new, tightly knit integration of the Wibbitz video creation tool and Brightcove ® (NASDAQ: BCOV), the global leader in video for business.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210713005375/en/
With smart automation driving Wibbitz video creation, the combination of Brightcove and Wibbitz is one of the easiest and most effective ways for companies to quickly create professional quality short-form videos that engage viewers, nurture sales leads through to closure, and provide valuable information to shareholders, customers, and employees.
Creators, even those with no experience, can now access Wibbitz from their Brightcove Video Cloud interface and intuitively create polished videos from scratch. Wibbitz provides templates and rights-cleared photos and music tracks, animations, transitions, video clips, and other media. Users can then distribute the newly created videos through the Brightcove platform to any person on any device and on any channel, anywhere in the world. The integration also makes it easy to use Wibbitz to refresh videos stored in a Brightcove library with new content or effects before redistribution.
“As a long-time Wibbitz user, I’m excited about the integration with Brightcove and the ability to easily bring more scale, security, and reliability to our video content,” said Marco Viganò, Chief Technology Officer, Condé Nast Italy. “We believe video is the most powerful communications tool to engage our audiences. To us, the Wibbitz and Brightcove combination is now a single, seamless experience of video creation, distribution, and optimization.”
“Creators use Wibbitz to tell their stories with video, and they need the most reliable, comprehensive, and effective solution to make sure those stories reach their audience. Brightcove hits the mark,” said Zohar Dayan, Chief Executive Officer, Wibbitz. “This partnership simplifies video workflows to make each step easier, from production to publishing and analytics, so media companies and enterprises can focus on sharing stories that drive real impact.”
“Although Brightcove can easily manage, play, and measure any video created in any tool, we want to help make creators’ lives easier,” said Namita Dhallan, Chief Product Officer, Brightcove. “That means lowering the barrier to creation, especially for organizations that want to quickly and easily build up video volume and execute new video strategies themselves. Wibbitz is a great way to do that.”
Wibbitz and Brightcove exchange all relevant data, including authentication via single sign-on, user profile information, and available video files. Wibbitz also helps organizations ensure that every video is on brand with the right logos, watermarks, custom fonts, and color palettes.
To try Wibbitz for free, visit here .
About Wibbitz
Wibbitz is a video creation company that empowers content teams to produce professional short-form video. The Wibbitz online platform makes it quick and easy to create video for social media, news & entertainment coverage, marketing, communications, recruitment, events, and more. Creators have access to customizable video templates, drag-and-drop editing tools, a team of in-house experts, and millions of licensed photos, videos, and soundtracks. Wibbitz powers video for leading brands including HubSpot, Bloomberg, Condé Nast, S&P Global, Bain & Company, BP, and more. Wibbitz was founded in 2011 and has offices in New York City, Tel Aviv, and Paris. For more information, visit www.wibbitz.com and follow @wibbitz .
About Brightcove Inc.
When video is done right, it can have a powerful and lasting effect. Hearts open. Minds change. Creativity thrives. Since 2004, Brightcove has been helping customers discover and experience the incredible power of video through its award-winning technology, empowering organizations in more than 70 countries across the globe to touch audiences in bold and innovative ways.
Brightcove achieves this by developing technologies once thought impossible, providing customer support without parallel or excuses, and leveraging the expertise and resources of a global infrastructure. Video is the world’s most compelling, exciting medium. Visit www.brightcove.com for more information. Video That Means Business.™
View source version on businesswire.com: https://www.businesswire.com/news/home/20210713005375/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ViaLase Announces First Patient Treated in IDE Clinical Trial Evaluating Its Femtosecond Laser Trabeculotomy for Open-Angle Glaucoma3.12.2025 14:00:00 CET | Press release
Prospective, randomized controlled trial compares novel femtosecond laser procedure to selective laser trabeculoplasty (SLT), advancing path to US commercialization ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient has been treated in its U.S. Investigational Device Exemption (IDE) clinical trial evaluating the company’s femtosecond laser trabeculotomy procedure for the management of glaucoma, a lifelong, progressive, and incurable disease that remains a leading cause of irreversible blindness worldwide. This prospective, multicenter, randomized, controlled trial evaluates the ViaLase procedure in comparison to selective laser trabeculoplasty (SLT), the current standard laser treatment for reducing intraocular pressure (IOP). This trial was designed in consultation with the FDA to achieve clearance and commercialization in the U.S. and thus represents one of the most rigorous e
Winchester Interconnect Launches LiteSPEed™ Cable: Faster, Lighter, Simpler Connectivity for Mission-Critical Systems3.12.2025 14:00:00 CET | Press release
Winchester Interconnect, an Aptiv company and leading supplier of high-performance interconnect solutions, today introduced LiteSPEed™ Cable, a next-generation single-pair Ethernet (SPE) solution that delivers 10-gigabit data rates in a dramatically smaller, lighter design. Built for the increasingly connected and space-constrained environments of aerospace, defense, industrial automation and next-generation mobility, LiteSPEed™ helps customers move more data with less cable, reducing weight, complexity, and cost while increasing system performance and reliability. “As systems become more intelligent and interconnected, engineers need lighter, more efficient ways to deliver power and data,” said Juan Contreres, director of product management. “LiteSPEed™ gives them a rugged, high-speed Ethernet solution that simplifies installation without compromising performance.” With advanced sensors, real-time analytics, and distributed control systems proliferating across industries, cabling has
Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA Mutations Directly From Pathology Slides3.12.2025 14:00:00 CET | Press release
Owkin shares promising validation results for BRCAura RUO, a clinical-grade research-use-only AI product designed to screen for germline BRCA1/2 mutations (gBRCAm) directly from digitized breast cancer pathology slides. Breast cancer remains the leading cause of cancer-related deaths among women worldwide. Identifying patients with germline BRCA1/2 mutations is essential for guiding targeted treatment decisions, but testing is not always consistently offered to eligible individuals, and implementation varies between countries. The model concept was initiated as part of Owkin’s ongoing partnership with Gustave Roussy and Centre Léon Bérard through PortrAIt, a French consortium dedicated to advancing precision medicine with AI-enabled digital pathology. Fostered through collaboration with AstraZeneca, as announced in October 2024, the development of BRCAura aims to accelerate and expand identification of BRCA mutations in patients with breast cancer. Strong validation across internationa
Adva Network Security achieves BSI approval for PQC-encrypted edge networking device3.12.2025 14:00:00 CET | Press release
News summary: Critical infrastructure, defense and governments need quantum-safe encryption at the edge to neutralize ‘harvest-now, decrypt-later’ risks FSP 150-XG118Pro (CSH) delivers quantum-safe encryption via software update, enabling seamless upgrades with no hardware changes BSI approval confirms the device’s compliance for government and defense use Adva Network Security today announced that the FSP 150-XG118Pro (CSH) 10Gbit/s edge device now delivers quantum-safe encryption based on post-quantum cryptography (PQC). This enhancement enables operators of critical network infrastructure (CNI) to secure data in motion and build future-ready networks. Certified by the German Federal Office for Information Security (BSI), the solution’s Ethernet encryption offers PQC crypto-agility via a software update, eliminating the need for hardware changes. With its new capabilities, the FSP 150-XG118Pro (CSH) is ideally suited for diverse high-security environments, ranging from national infra
Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing3.12.2025 14:00:00 CET | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President: Toshiaki Nagasato) today announced a strategic equity investment in Lyric Bio, Inc. (Head Office: San Carlos, USA, founded by Chief Executive Officer: Kayj Shannon and Chief Scientific Officer Melanie Matheu). Through this investment, Meiji Seika Pharma seeks to accelerate the early-stage development of Lyric Bio’s innovative platform for producing human immunoglobulin (IVIg), explore donation-independent manufacturing methods, and lay the groundwork for a more resilient, high-quality supply of plasma-derived therapeutics to meet increasing global demand. Lyric Bio is developing a next-generation biomanufacturing platform for IVIg production. The company’s approach uses tissue-mimicking bioreactors built on a proprietary laser-printed cellular substrate that enables ultra high-density cell growth and has the potential to deliver more than 1,000 IVIg doses from a single donor. This investment will accelerate Lyric Bio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom